Literature DB >> 19848609

Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up.

Long Fu Xi1, James P Hughes, Zoe R Edelstein, Nancy B Kiviat, Laura A Koutsky, Constance Mao, Jesse Ho, Mark Schiffman.   

Abstract

BACKGROUND: Studies of viral load-associated persistence of human papillomavirus (HPV) infection are rare, with inconsistent results reported.
METHODS: The study subjects were 741 and 289 women who were positive for HPV type 16 (HPV-16) and HPV type 18 (HPV-18), respectively, at the time of enrollment into in the ASCUS-LSIL (Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion) Triage Study and who returned 1 or more times for HPV testing during a biannual 2-year follow-up. The numbers of HPV-16 and HPV-18 copies per nanogram of cellular DNA at baseline were measured by use of real-time polymerase chain reaction.
RESULTS: Women with, compared with women without, persistent infection at month 6 of follow-up had a higher viral load at enrollment (P< .001, for HPV-16; P=.01, for HPV-18). The association of each 1-log(10) increase in viral load with persistence of HPV-16 or HPV-18 during the first 6 months of the study was statistically significant among women with multiple HPV types at enrollment (for HPV-16: odds ratio [OR], 1.53 [95% confidence interval {CI}, 1.29-1.82]; for HPV-18: OR, 1.35 [95% CI, 1.09-1.68]) but not among women with monotype infections (in tests assessing the interaction between viral load and coinfection, P=.002 for HPV-16 and P=.34 for HPV-18). Among women who continued to have positive results at month 6, 12, or 18, persistence of infection for another 6 months was unassociated with the viral load at baseline.
CONCLUSION: Prevalent infection with a higher viral load of HPV-16 or HPV-18 was associated with short- but not long-term persistence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19848609      PMCID: PMC2783915          DOI: 10.1086/647993

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

Authors:  Ligia A Pinto; Raphael Viscidi; Clayton D Harro; Troy J Kemp; Alfonso J García-Piñeres; Matthew Trivett; Franklin Demuth; Douglas R Lowy; John T Schiller; Jay A Berzofsky; Allan Hildesheim
Journal:  Virology       Date:  2006-07-24       Impact factor: 3.616

2.  Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study.

Authors:  Satu-Maria A Kulmala; Irena P Shabalova; Nikolay Petrovitchev; Kari J Syrjänen; Ulf B Gyllensten; Bo C Johansson; Stina M Syrjänen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

3.  Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

Authors:  Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

4.  A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.

Authors:  K L Liaw; A Hildesheim; R D Burk; P Gravitt; S Wacholder; M M Manos; D R Scott; M E Sherman; R J Kurman; A G Glass; S M Anderson; M Schiffman
Journal:  J Infect Dis       Date:  2000-11-16       Impact factor: 5.226

5.  Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan.

Authors:  Chyong-Huey Lai; Angel Chao; Chee-Jen Chang; Fang-Yu Chao; Huei-Jean Huang; Swei Hsueh; Cheng-Tao Lin; Hui-Hsin Cheng; Chu-Chun Huang; Jung-Erh Yang; Tzu-I Wu; Hung-Hsueh Chou; Ting-Chang Chang
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

6.  Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3.

Authors:  Long Fu Xi; Nancy B Kiviat; Denise A Galloway; Xiao-Hua Zhou; Jesse Ho; Laura A Koutsky
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

7.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

8.  The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.

Authors:  Jeong-Yeol Park; Kyung Hee Lee; Seung Myung Dong; Sokbom Kang; Sang-Yoon Park; Sang-Soo Seo
Journal:  Gynecol Oncol       Date:  2008-01-04       Impact factor: 5.482

9.  Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Authors:  Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

10.  The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.

Authors:  Ali Rowhani-Rahbar; Stephen E Hawes; Papa Salif Sow; Papa Toure; Qinghua Feng; Ahmadou Dem; Birama Dembele; Cathy W Critchlow; Ibraham N'Doye; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2007-08-07       Impact factor: 5.226

View more
  16 in total

1.  HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP.

Authors:  Brian Lowe; Lori Kobayashi; Attila Lorincz; Rick Mallonee; Dominic O'Neil; Ha Thai; Irina Nazarenko
Journal:  J Mol Diagn       Date:  2010-09-16       Impact factor: 5.568

2.  Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes.

Authors:  Lanlan Wei; Anastacia M Griego; Ming Chu; Michelle A Ozbun
Journal:  Carcinogenesis       Date:  2014-07-26       Impact factor: 4.944

3.  Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya.

Authors:  Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Kawango Agot; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith
Journal:  J Infect Dis       Date:  2014-09-26       Impact factor: 5.226

4.  Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Joseph J Carter; Ruchi Garg; Rachel L Winer; Qinghua Feng; Denise A Galloway; Laura A Koutsky
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

5.  Association of Human Papillomavirus 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Authors:  Xia Liu; Mark Schiffman; Ayaka Hulbert; Zhonghu He; Zhenping Shen; Laura A Koutsky; Long Fu Xi
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

6.  Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.

Authors:  Long Fu Xi; James P Hughes; Philip E Castle; Zoe R Edelstein; Chunhui Wang; Denise A Galloway; Laura A Koutsky; Nancy B Kiviat; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-03-16       Impact factor: 5.226

7.  High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men.

Authors:  Mary K Grabowski; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Stephen Watya; Thomas C Quinn; Aaron A R Tobian
Journal:  Sex Transm Infect       Date:  2014-01-30       Impact factor: 3.519

8.  Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda.

Authors:  Mitzie-Ann Davis; Ronald H Gray; Mary K Grabowski; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Stephen Watya; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian
Journal:  Int J Cancer       Date:  2013-03-07       Impact factor: 7.396

9.  High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.

Authors:  Anil K Chaturvedi; Barry I Graubard; Robert K L Pickard; Weihong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2014-03-12       Impact factor: 5.226

10.  Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.

Authors:  Rachel L Winer; Long Fu Xi; Zhenping Shen; Joshua E Stern; Laura Newman; Qinghua Feng; James P Hughes; Laura A Koutsky
Journal:  Int J Cancer       Date:  2013-10-18       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.